Abbott (NYSE: ABT) has approved the separation of its research-based pharmaceuticals business, which will be known as AbbVie Inc., and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE